Gholamali Rahnavard
George Washington University
https://www.rahnavard.org/
https://publichealth.gwu.edu/departments/biostatistics-and-bioinformatics/ali-r…
We are developing robust, repeatable, and accessible tools to integrate and analyze the diversity of data becoming available in the face of the COVID-19 pandemic. Also, we apply these techniques to study genetic variability in the SARS-CoV-2 coronavirus, which causes COVID-19, and to identify associations with clinical variables of health outcomes. We also investigate a combination of metabolomics and proteomics data to characterize their change across a spectrum of COVID-19 severities.
- Looking for investigating COVID-19 treatments outcome in molecular level and deep learning of COVID omics.
- Seeking scientific expertise in experimental test and methodological development.
- Computational Biology
- Metabolomics
- Metagenomics
- Viral Genome
bioinformatics statistical computational genome genomics deep learning COVID-19 omics metabolomics microbiome